Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026)

Nuvectis Pharma's (NVCT) quarterly Prepaid Assets came in at $268000.0 in Q1 2026, down 5.63% year-on-year from $284000.0 in Q1 2025, and up 257.33% quarter-over-quarter from $75000.0 in Q4 2025.

Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026) Analysis & Trends

Nuvectis Pharma has disclosed Prepaid Assets across 6 years of filings, most recently posting $268000.0 for Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $268000.0, down 5.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $268000.0 (down 5.63% YoY), and the FY2025 annual result was $75000.0, up 1.35% from the prior year.
  • Prepaid Assets came in at $268000.0 for Q1 2026 at Nuvectis Pharma, up from $75000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.2 million in Q3 2022 to a low of $59000.0 in Q4 2023.
  • The 5-year median for Prepaid Assets is $250000.0 (2024), against an average of $364823.5.
  • Across the five-year window, Prepaid Assets surged 352.75% in 2022 and tumbled 85.68% in 2023, its largest moves.
  • Nuvectis Pharma's Prepaid Assets stood at $412000.0 in 2022, then sank by 85.68% to $59000.0 in 2023, then increased by 25.42% to $74000.0 in 2024, then climbed by 1.35% to $75000.0 in 2025, then jumped by 257.33% to $268000.0 in 2026.
  • The last three Prepaid Assets figures came in at $268000.0 (Q1 2026), $75000.0 (Q4 2025), and $145000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Nuvectis Pharma 274.90 Mn 274.90 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 268,000.00
Dec 31, 2025 75,000.00
Sep 30, 2025 145,000.00
Jun 30, 2025 214,000.00
Mar 31, 2025 284,000.00
Dec 31, 2024 74,000.00
Sep 30, 2024 138,000.00
Jun 30, 2024 182,000.00
Mar 31, 2024 250,000.00
Dec 31, 2023 59,000.00
Sep 30, 2023 203,000.00
Jun 30, 2023 341,000.00
Mar 31, 2023 740,000.00
Dec 31, 2022 412,000.00
Sep 30, 2022 1.23 Mn
Jun 30, 2022 666,000.00
Mar 31, 2022 925,000.00
Dec 31, 2021 91,000.00